KVUE Kenvue Inc.
Company Analysis
Latest News
Kenvue Faces 500+ Revived Tylenol Lawsuits, Court Reinstates Expert Testimony
The 2nd U.S. Circuit Court of Appeals in Manhattan revived more than 500 lawsuits against Kenvue. These claims allege a link between prenatal Tylenol use and...
🟢 Kenvue Inc. is trading 5.01% up today as investors rotate into defensive consumer staples
Kenvue Inc. is trading 5.01% up at $17.73 as investors rotate into defensive consumer staples during a broad risk-off session. • The move comes despite no...
🟢 Kenvue Inc. is trading 4.0% up today on potential defensive rotation
Kenvue Inc. is trading at $17.56 (+4.03%) as the stock shows strength despite a broader market selloff that is pressuring many other equities. • No...
Kenvue's first quarter 2026 adjusted EPS beat estimates, but organic growth of 0.7% was sluggish.
Kenvue reported first quarter 2026 net sales of $3.91 billion, a 4.5% year-over-year increase, and adjusted diluted EPS of $0.32, beating analyst estimates....
Kenvue Inc. Q1 2026 Earnings Preview: What Analysts Expect on May 07, 2026
Kenvue is expected to report Q1 2026 revenue of $3.84 billion and adjusted EPS of $0.27, as the stock trades around $17.44 against an average analyst price...